Iribarren ME, et al. Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma. P2520. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
EGFR-TKI’s bij NSCLC: openstaande vragen rondom adjuvant osimertinib
okt 2020 | Longoncologie